The best stocks to invest $1,000 in right now

Two young boys sit at a desk wearing helmets with lightbulbs, indicating two ASX 200 shares that a broker has recommended as buys today

With the S&P/ASX 200 Index (ASX: XJO) down about 5.4% from its October record highs, it’s arguably a good time to reassess the markets as we approach the end of 2025 and look for some of the best stocks available to invest in.

It’s still hard to call the ASX cheap as a whole, despite this dip. But it’s what we have right now, so we may as well work with it.

If I had $1,000 to invest in this market today, there are two best ASX stocks I would probably go for. Neither are screaming buys, but both are still trading at reasonable valuations for a long-term investor. At least in my view. Let’s dive in.

2 of the ASX’s best stocks to buy with $1,000 today

Wesfarmers Ltd (ASX: WES)

First up, we have Wesfarmers. Wesfarmers is the name behind some of the most successful retailers in the country, including OfficeWorks, Kmart and Bunnings. Wesfarmers also owns a sprawl of other businesses though, ranging from Wesfarmers Chemicals, Energy and Fertilisers (WesCEF) to the Priceline pharmacy chain.

I like this company as a long-term investment because of this inherent diversification, as well as Wesfarmers’ decades-long track record of delivering results for its shareholders. It has prudently managed its underlying companies with aplomb, delivering meaningful capital growth over many years. It has also been a star in the dividend department, consistently raising its fully franked payouts over time.

At just over $80 a share today, I wouldn’t call this stock particularly cheap. But it’s a lot better than the $95 we were seeing just a few months ago. If you’re stuck for a place to put $1,000 right now, you could do worse than this conglomerate.

MFF Capital Investments Ltd (ASX: MFF)

Next up, we have the listed investment company (LIC) MFF Capital. Like most LICs, MFF owns and manages a portfolio of underlying investments on behalf of its shareholders.

In this case, those investments are some of the best stocks from the United States. MFF follows a Warren Buffett-inspired playbook of buying high-quality stocks at prices that make sense, and holding them through thick and thin. Some of its longest-held positions include Amazon, Alphabet, Visa, American Express and Mastercard. All have been in the MFF portfolio for years.

This week, MFF told the market that its portfolio was worth $5.30 per share on a pre-tax basis. Yet you can buy its shares for $4.81 each at recent pricing. Given this LIC’s impressive performance and savvy investment strategy, I think it is one of the best stocks on the ASX. I would be happy to put $1,000 in it today.

The post The best stocks to invest $1,000 in right now appeared first on The Motley Fool Australia.

Should you invest $1,000 in Mff Capital Investments right now?

Before you buy Mff Capital Investments shares, consider this:

Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Mff Capital Investments wasn’t one of them.

The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

And right now, Scott thinks there are 5 stocks that may be better buys…

* Returns as of 18 November 2025

.custom-cta-button p {
margin-bottom: 0 !important;
}

More reading

American Express is an advertising partner of Motley Fool Money. Motley Fool contributor Sebastian Bowen has positions in Alphabet, Amazon, American Express, Mastercard, Mff Capital Investments, Visa, and Wesfarmers. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Alphabet, Amazon, Mastercard, Visa, and Wesfarmers. The Motley Fool Australia has recommended Alphabet, Amazon, Mastercard, Mff Capital Investments, Visa, and Wesfarmers. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *